These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37079243)

  • 1. Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study.
    Srivastava V; Naik B; Godara P; Das D; Mattaparthi VSK; Prusty D
    Mol Divers; 2024 Jun; 28(3):1093-1107. PubMed ID: 37079243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus.
    Hossain FMA; Bappy MNI; Robin TB; Ahmad I; Patel H; Jahan N; Rabbi MGR; Roy A; Chowdhury W; Ahmed N; Prome AA; Rani NA; Khan P; Zinnah KMA
    J Biomol Struct Dyn; 2024 Aug; 42(12):6091-6107. PubMed ID: 37403283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
    Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ
    J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning and classical MD simulation to identify inhibitors against the P37 envelope protein of monkeypox virus.
    Rout M; Dey S; Mishra S; Panda S; Singh MK; Sinha R; Dehury B; Pati S
    J Biomol Struct Dyn; 2024 May; 42(8):3935-3948. PubMed ID: 37221882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs.
    Sahoo AK; Augusthian PD; Muralitharan I; Vivek-Ananth RP; Kumar K; Kumar G; Ranganathan G; Samal A
    Mol Divers; 2023 Oct; 27(5):2169-2184. PubMed ID: 36331784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis.
    Sib Tul Hassan Shah S; Naeem I
    J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach.
    Achilonu I; Iwuchukwu EA; Achilonu OJ; Fernandes MA; Sayed Y
    J Mol Graph Model; 2020 Dec; 101():107730. PubMed ID: 32920239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease.
    Bhattacharjee A; Ahammad I; Chowdhury ZM; Das KC; Keya CA; Salimullah M
    Mol Biotechnol; 2024 Apr; 66(4):626-640. PubMed ID: 36357534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
    Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
    Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Repurposed Drugs against Monkeypox Virus.
    Lam HYI; Guan JS; Mu Y
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing FDA approved drugs against monkeypox virus DNA dependent RNA polymerase: virtual screening, normal mode analysis and molecular dynamics simulation studies.
    Khan AAS; Yousaf MA; Azhar J; Maqbool MF; Bibi R
    Virusdisease; 2024 Jun; 35(2):260-270. PubMed ID: 39071866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules.
    Arasu MV; Vijayaragavan P; Purushothaman S; Rathi MA; Al-Dhabi NA; Gopalakrishnan VK; Choi KC; Ilavenil S
    J Infect Public Health; 2023 May; 16(5):784-791. PubMed ID: 36958173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
    Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lokhande KB; Shrivastava A; Singh A
    J Biomol Struct Dyn; 2023; 41(23):14259-14274. PubMed ID: 36841550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19.
    Talluri S
    Comb Chem High Throughput Screen; 2021; 24(5):716-728. PubMed ID: 32798373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays.
    Huo S; Wu L; Huang B; Liu N; Sun J; Ye F; Deng Y; Chen J; Gong L; Zhu W; Xu Z; Tan W
    Emerg Microbes Infect; 2024 Dec; 13(1):2373309. PubMed ID: 38922308
    [No Abstract]   [Full Text] [Related]  

  • 18. Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox.
    Paul D; Saha S; Basu S; Chakraborti T
    Sci Rep; 2024 Aug; 14(1):18736. PubMed ID: 39134619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?
    Dodaro A; Pavan M; Moro S
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
    Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.